The fermented milk can be a natural ally against obesity? Investigation of bovine milk fermentation by Lacticaseibacillus casei LBC 237, screening, and In silico predictions of bioactive peptides for obesity control

Abstract

The increasing quest for therapeutic alternatives in treating non-communicable chronic diseases like obesity has propelled research into bioactive peptides, with a particular focus on milk due to its rich protein composition and associated health benefits. Milk fermentation, a traditional process in dairy production, enhances the bioactivity of peptides, broadening their potential therapeutic uses. This study investigated the anti-obesity potential of peptides from bovine milk fermented by Lacticaseibacillus casei LBC 237, identifying 143 peptides, notably LGPV and EVPMP. In silico analyses revealed that LGPV and EVPMP biopeptides exhibited significant interactions with target proteins, employing various molecular interactions such as Van der Waals forces, hydrogen bonds, and electrostatic interactions. These peptides shared common binding sites in some enzymes, suggesting a similar mode of interaction between molecule and target protein, akin to key pharmaceuticals recommended for treating these pathologies. Furthermore, amino acid characteristics present in the peptides, including hydrophobic residues like Leucine, Glutamate, Valine, and Proline, proved essential for their bioactive and inhibitory activities. These findings highlight the potential of LGPV and EVPMP biopeptides as therapeutic agents in managing obesity and metabolic disorders. They provide important insights into their mechanisms of action, paving the way for future research to apply them practically in preventing and treating metabolic conditions.

Keywords

Biopeptides / Molecular docking / HMG-CoAR / PL / FAS

References

[1] Hill JO, Wyatt HR, Peters JC. Obesity. Our World Data. 2017;126(1):126–132.

[2] Tabish SA. Lifestyle diseases: consequences, characteristics, causes and control. J Cardiol Curr Res. 2017;9(3):326.

[3] OMS OM da S. Obesity and Overweight. World Health Organization; 2021. https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight. Accessed November 6, 2022. June 9.

[4] Theilade S, Christensen MB, Vilsbøll T, Knop FK. An overview of obesity mechanisms in humans: endocrine regulation of food intake, eating behaviour and common determinants of body weight. Diabetes, Obes Metab. 2021;23(S1):17–35.

[5] Morais JBS, Severo JS, Beserra JB, et al. Association between cortisol, insulin resistance and zinc in obesity: a mini-review. Biol Trace Elem Res. 2019;191(2): 323–330.

[6] Chu JJ, Mehrzad R. Pathophysiology of obesity. Inflamm Obes A New Nov Approach to Manag Obes its Consequences. July 2021:31–47. https://doi.org/10.1016/B978-0-323-90960-0.00003-5.

[7] Kojta I, Chacińska M, Błachnio-Zabielska A. Obesity, bioactive lipids, and adipose tissue inflammation in insulin resistance. Nutr. 2020;12:1305.

[8] World Health Organization. World obesity day 2022 – accelerating action to stop obesity. Worl Health Organization; 2022. www.who.int/news/item/04-03-2022-world-obesity-day-2022-accelerating-action-to-stop-obesity. Accessed April 21, 2023.

[9] World Obesity Federation. World obesity Atlas 2022. In: Lobstein T, Brinsden H, Neveux M, Barata Cavalcanti O, eds. Inglaterra: World Obesity Federation; 2022. s3-e u-west-1.amazonaws.com/wof-files/World_Obesity_Atlas_2022.pdf. Accessed April 21, 2023.

[10] World Obesity Federation. Prevalence of obesity. World Obesity Federation; 2022. www.worldobesity.org/about/about-obesity/prevalence-of-obesity. Accessed April 21, 2023.

[11] Lin X, Li H. Obesity: epidemiology, pathophysiology, and therapeutics. Front Endocrinol. 2021;12:1070.

[12] Singh BP, Aluko RE, Hati S, Solanki D. Bioactive peptides in the management of lifestyle-related diseases: current trends and future perspectives. Crit Rev Food Sci Nutr. 2021;62(17):4593–4606.

[13] Chelliah R, Wei S, Daliri EB-M, et al. The role of bioactive peptides in diabetes and obesity. Foods. 2021;10(9):2220.

[14] Franca-Oliveira G, Fornari T, Hernández-Ledesma B. A review on the extraction and processing of natural source-derived proteins through eco-innovative approaches. Processes. 2021;9(9).

[15] Iwaniak A, Darewicz M, Minkiewicz P. Peptides derived from foods as supportive diet components in the prevention of metabolic syndrome. Compr Rev Food Sci Food Saf. 2018;17(1):63–81.

[16] Tahavorgar A, Vafa M, Shidfar F, Gohari M, Heydari I. Whey protein preloads are more beneficial than soy protein preloads in regulating appetite, calorie intake, anthropometry, and body composition of overweight and obese men. Nutr Res. 2014;34(10):856–861.

[17] Bouglé D, Bouhallab S. Dietary bioactive peptides: human studies. Crit Rev Food Sci Nutr. 2017;57(2):335–343.

[18] Lai C-S, Wu J-C, Pan M-H. Molecular mechanism on functional food bioactives for anti-obesity. Curr Opin Food Sci. 2015;2:9–13.

[19] Torres-Fuentes C, Schellekens H, Dinan TG, Cryan JF. A natural solution for obesity: bioactives for the prevention and treatment of weight gain. A review. Nutr Neurosci. 2015;18(2):49–65.

[20] Martínez-Sánchez SM, Gabaldón-Hernández JA, Montoro-García S. Unravelling the molecular mechanisms associated with the role of food-derived bioactive peptides in promoting cardiovascular health. J Funct Foods. 2020;64:103645.

[21] Hou F, Ding W, Qu W, et al. Alkali solution extraction of rice residue protein isolates: influence of alkali concentration on protein functional, structural properties and lysinoalanine formation. Food Chem. 2017;218:207–215.

[22] Kempka AP, Krüger RL, Valduga E, et al. Formulation of a peach-flavored dairy drink using alternative substrates and probiotic culture. Food Sci Technol. 2008; 28(SUPPL.):170–177.

[23] Artifon SES, Sumny EH, Fabris T, et al. Biosynthesis of the acid protease produced by Lacticaseibacillus casei LBC 237 and Limosilactobacillus fermentum LBF 433 and their potential application in the bovine milk clotting. Food Biosci. 2023;54: 102879.

[24] Bellaver EH, Eliza Redin E, Militão da Costa I, Schittler Moroni L, Pinto Kempka A. Food peptidomic analysis of bovine milk fermented by Lacticaseibacillus casei LBC 237: in silico prediction of bioactive peptides and anticancer potential. Food Res Int. 2024;180:114060.

[25] Liu C, Guo Z, Yang Y, et al. Identification of dipeptidyl peptidase-IV inhibitory peptides from yak bone collagen by in silico and in vitro analysis. Eur Food Res Technol. 2022;248(12):3059–3069.

[26] Morozov V, Rodrigues CHM, Ascher DB. CSM-toxin: a web-server for predicting protein toxicity. Pharmaceutics. 2023;15(2).

[27] Perçin PS, Karakaya S. Evaluation of protein profiles, bioactivity, allergenicity and toxicity of peptides generated after in silico digestion of common wheat and einkorn wheat. Turkish J Agric - Food Sci Technol. 2020;8(4):901–911.

[28] Yang H, Lou C, Sun L, et al. admetSAR 2.0: web-service for prediction and optimization of chemical ADMET properties. Bioinformatics. 2019;35(6): 1067–1069.

[29] Gasteiger E, Hoogland C, Gattiker A, et al. Protein Identification and Analysis Tools on the ExPASy Server. Springer; 2005.

[30] O’Boyle NM, Banck M, James CA, Morley C, Vandermeersch T, Hutchison GR. Open Babel: an open chemical toolbox. J Cheminform. 2011;3(1):33.

[31] Backman TWH, Cao Y, Girke T. ChemMine tools: an online service for analyzing and clustering small molecules. Nucleic Acids Res. 2011;39(suppl_2):W486–W491.

[32] Boga S, Bouzada D, Garcia Pena D, Vazquez Lopez M, Vázquez ME. Sequence-specific DNA recognition with designed peptides. European J Org Chem. 2018; 2018(3):249–261.

[33] Bellaver EH, Kempka AP. Potential of milk-derived bioactive peptides as antidiabetic, antihypertensive, and xanthine oxidase inhibitors: a comprehensive bibliometric analysis and updated review. Amino Acids. 2023:1–27.

[34] Giannetto A, Esposito E, Lanza M, et al. Protein hydrolysates from anchovy (Engraulis encrasicolus) waste: in vitro and in vivo biological activities. Mar Drugs. 2020;18(2):86.

[35] Marcone S, Belton O, Fitzgerald DJ. Milk-derived bioactive peptides and their health promoting effects: a potential role in atherosclerosis. Br J Clin Pharmacol. 2017;83(1):152–162.

[36] Yilmaz B, Sharma H, Melekoglu E, Ozogul F. Recent developments in dairy kefirderived lactic acid bacteria and their health benefits. Food Biosci. 2022;46:101592.

[37] Ebringer L, Ferenčík M, Krajčovič J. Beneficial health effects of milk and fermented dairy products. Folia Microbiol (Praha). 2008;53:378–394.

[38] Nagaoka S, Futamura Y, Miwa K, et al. Identification of novel hypocholesterolemic peptides derived from bovine milk β-lactoglobulin. Biochem Biophys Res Commun. 2001;281(1):11–17.

[39] Oriá RB, Brito GA de C. Sistema Digestório: Integração Básico-Clínica. Blusher: São Paulo; 2016.

[40] Jahandideh F, Bourque SL, Wu J. A comprehensive review on the glucoregulatory properties of food-derived bioactive peptides. Food Chem X. 2022;13:100222.

[41] Jang EH, et al. Novel black soy peptides with antiobesity effects: activation of leptin-like signaling and AMP-activated protein kinase. Int J Obes. 2008;32(7): 1161–1170.

[42] Li S, Liu L, He G, Wu J. Molecular targets and mechanisms of bioactive peptides against metabolic syndromes. Food Funct. 2018;9(1):42–52.

[43] Chakrabarti S, Wu J. Milk-derived tripeptides IPP (Ile-Pro-Pro) and VPP (Val-Pro-Pro) promote adipocyte differentiation and inhibit inflammation in 3T3-F442A cells. PLoS One. 2015;10(2):e0117492.

[44] Pedersen NL-R, Nagain-Domaine C, Mahé S, Chariot J, Rozé C, Tomé D. Caseinomacropeptide specifically stimulates exocrine pancreatic secretion in the anesthetized rat. Peptides. 2000;21(10):1527–1535.

[45] Rafiq S, Huma N, Pasha I, Sameen A, Mukhtar O, Khan MI. Chemical composition, nitrogen fractions and amino acids profile of milk from different animal species. Asian-Australasian J Anim Sci. 2016;29(7):1022–1028.

[46] Hall WL, Millward DJ, Long SJ, Morgan LM. Casein and whey exert different effects on plasma amino acid profiles, gastrointestinal hormone secretion and appetite. Br J Nutr. 2003;89(2):239–248.

[47] Krissansen GW. Emerging health properties of whey proteins and their clinical implications. J Am Coll Nutr. 2007;26(6):713S–723S.

[48] Mohanty DP, Mohapatra S, Misra S, Sahu PS. Milk derived bioactive peptides and their impact on human health – a review. Saudi J Biol Sci. 2016;23(5):577–583.

[49] de Queiroz JCF, Alonso-Vale MIC, Curi R, Lima FB. Controle da adipogênese porácidos graxos. Arq Bras Endocrinol Metabol. 2009;53(5):582–594.

[50] Jakab J, Miškić B, Mikšić Š, et al. Adipogenesis as a potential anti-obesity target: a review of pharmacological treatment and natural products. Diabetes Metab Syndr Obes. 2021;14:67–83.

[51] D’Souza K, Mercer A, Mawhinney H, Pulinilkunnil T, Udenigwe CC, Kienesberger PC. Whey peptides stimulate differentiation and lipid metabolism in adipocytes and ameliorate lipotoxicity-induced insulin resistance in muscle cells. Nutrients. 2020;12(2).

[52] Rajic A, Dhulia J, Hosking CG, Autelitano DJ. A novel dairy-derived isolate that inhibits adipogenesis and significantly reduces weight gain in a high fat animal model. Int Dairy J. 2010;20(7):480–486.

[53] Kim Y-M, Kim I-H, Choi J, Lee M, Nam T. The anti-obesity effects of a tuna peptide on 3T3-L1 adipocytes are mediated by the inhibition of the expression of lipogenic and adipogenic genes and by the activation of the Wnt/β-catenin signaling pathway. Int J Mol Med. 2015;36:327–334.

[54] Fan X, Cui Y, Zhang R, Zhang X. Purification and identification of anti-obesity peptides derived from Spirulina platensis. J Funct Foods. 2018;47:350–360.

[55] Akimova EV, Frolova EY, Petelina TI, Gakova AA. Obesity and hypercholesterolemia. Int Hear Vasc Dis J. 2019;7(24):10–15.

[56] De Castro RJS, Sato HH. Biologically active peptides: processes for their generation, purification and identification and applications as natural additives in the food and pharmaceutical industries. Food Res Int. 2015;74:185–198.

[57] Li J, Bollati C, d’Adduzio L, et al. Food-derived peptides with hypocholesterolemic activity: production, transepithelial transport and cellular mechanisms. Trends Food Sci Technol. 2024;143:104279.

[58] Boachie R, Yao S, Udenigwe CC. Molecular mechanisms of cholesterol-lowering peptides derived from food proteins. Curr Opin Food Sci. 2018;20:58–63.

[59] Nong NTP, Hsu J-L. Bioactive peptides: an understanding from current screening methodology. Processes. 2022;10(6):1114.

[60] Coelho MS, Soares-Freitas RAM, Arêas JAG, Gandra EA, Salas-Mellado M, de las M. Peptides from chia present antibacterial activity and inhibit cholesterol synthesis. Plant Foods Hum Nutr. 2018;73(2):101–107.

[61] Soares RAM, Mendonça S, Castro Lía De , Menezes ACCCC, Arêas JAG. Major peptides from amaranth (Amaranthus cruentus) protein inhibit HMG-CoA reductase activity. Int J Mol Sci. 2015;16(2):4150–4160.

[62] Chen G-W, Yang M-H. Production and purification of novel hypocholesterolemic peptides from lactic fermented Spirulina platensis through high hydrostatic pressure-assisted protease hydrolysis. Catalysts. 2021;11(8).

[63] Shi W, Hou T, Guo D, He H. Evaluation of hypolipidemic peptide (Val-Phe-Val-Arg-Asn) virtual screened from chickpea peptides by pharmacophore model in high-fat diet-induced obese rat. J Funct Foods. 2019;54:136–145.

[64] Fatchiyah F, Natasia SC. Inhibition potency of HMGR enzyme against hypercholesterolemia by bioactive peptides of CSN1S2 protein from caprine milk. In: AIP Conference Proceedings. Vol. 2021. AIP Publishing; 2018.

[65] Yamauchi R, Ohinata K, Yoshikawa M. β-Lactotensin and neurotensin rapidly reduce serum cholesterol via NT2 receptor. Peptides. 2003;24(12):1955–1961.

[66] Jiang X, Pan D, Zhang T, et al. Novel milk casein-derived peptides decrease cholesterol micellar solubility and cholesterol intestinal absorption in Caco-2 cells. J Dairy Sci. 2020;103(5):3924–3936.

[67] Mudgil P, Baba WN, Alneyadi M, Ali Redha A, Maqsood S. Production, characterization, and bioactivity of novel camel milk-based infant formula in comparison to bovine and commercial sources. LWT. 2022;154:112813.

[68] Mudgil P, Baba WN, Kamal H, et al. A comparative investigation into novel cholesterol esterase and pancreatic lipase inhibitory peptides from cow and camel casein hydrolysates generated upon enzymatic hydrolysis and in-vitro digestion. Food Chem. 2022;367:130661.

[69] Wang J, Zhou M, Wu T, Fang L, Liu C, Min W. Novel anti-obesity peptide (RLLPH) derived from hazelnut (Corylus heterophylla Fisch) protein hydrolysates inhibits adipogenesis in 3T3-L1 adipocytes by regulating adipogenic transcription factors and adenosine monophosphate-activated protein kinase (AMPK. J Biosci Bioeng. 2020;129(3):259–268.

[70] Pak VV, Sagdullaev SS, Pak AV, Khojimatov OK. Modeling of hydrophobic tetrapeptides as a competitive inhibitor for HMG-CoA reductase. J Mol Struct. 2023; 1293:136248.

[71] Deng X, Ma J, Song M, et al. Effects of products designed to modulate the gut microbiota on hyperlipidaemia. Eur J Nutr. 2019;58:2713–2729.

[72] Solieri L, De Vero L, Tagliazucchi D. Peptidomic study of casein proteolysis in bovine milk by Lactobacillus casei PRA205 and Lactobacillus rhamnosus PRA331. Int Dairy J. 2018;85:237–246.

[73] Koirala P, Dahal M, Rai S, et al. Dairy milk protein–derived bioactive peptides: avengers against metabolic syndrome. Curr Nutr Rep. 2023:1–19.

[74] Bechara C, Sagan S. Cell-penetrating peptides: 20 years later, where do we stand? FEBS Lett. 2013;587(12):1693–1702.

[75] Deng L, Du C, Song P, Chen T, Rui S, Armstrong DG. Molecular mechanisms of dietary bioactive compounds in redox balance and metabolic disorders. Oxid Med Cell Longev. 2021;2021:1–11.

[76] Sun X, Acquah C, Aluko RE, Udenigwe CC. Considering food matrix and gastrointestinal effects in enhancing bioactive peptide absorption and bioavailability. J Funct Foods. 2020;64:103680.

[77] Chen Y, Guarnieri MT, Vasil AI, Vasil ML, Mant CT, Hodges RS. Role of peptide hydrophobicity in the mechanism of action of alpha-helical antimicrobial peptides. Antimicrob Agents Chemother. 2007;51(4):1398–1406.

[78] Killian JA, von Heijne G. How proteins adapt to a membrane–water interface. Trends Biochem Sci. 2000;25(9):429–434.

[79] Salonen LM, Ellermann M, Diederich F. Aromatic rings in chemical and biological recognition: energetics and structures. Angew Chemie Int Ed. 2011;50(21): 4808–4842.

[80] Li-Chan ECY. Bioactive peptides and protein hydrolysates: research trends and challenges for application as nutraceuticals and functional food ingredients. Curr Opin Food Sci. 2015;1(1):28–37.

[81] Toledo MEO, de Mejia EG, Sivaguru M, Amaya-Llano SL. Common bean (Phaseolus vulgaris L.) protein-derived peptides increased insulin secretion, inhibited lipid accumulation, increased glucose uptake and reduced the phosphatase and tensin homologue activation in vitro. J Funct Foods. 2016;27:160–177.

[82] Lammi C, Zanoni C, Arnoldi A. IAVPGEVA, IAVPTGVA, and LPYP, three peptides from soy glycinin, modulate cholesterol metabolism in HepG2 cells through the activation of the LDLR-SREBP2 pathway. J Funct Foods. 2015;14:469–478.

[83] Silva M, Philadelpho B, Santos J, et al. IAF, QGF, and QDF peptides exhibit cholesterol-lowering activity through a statin-like HMG-CoA reductase regulation mechanism: in silico and in vitro approach. Int J Mol Sci. 2021;22(20):11067.

[84] Zaky AA, Simal-Gandara J, Eun J-B, Shim J-H, Abd El-Aty AM. Bioactivities, applications, safety, and health benefits of bioactive peptides from food and byproducts: a review. Front Nutr. 2022;8:815640.

[85] Korhonen H, Pihlanto A. Bioactive peptides: production and functionality. Int Dairy J. 2006;16(9):945–960.

[86] Wang L, Wang N, Zhang W, et al. Therapeutic peptides: current applications and future directions. Signal Transduct Target Ther. 2022;7(1):48.

[87] Hartmann R, Wal J-M, Bernard H, Pentzien A-K. Cytotoxic and allergenic potential of bioactive proteins and peptides. Curr Pharm Des. 2007;13(9):897–920.

[88] Cunsolo V, Saletti R, Muccilli V, Gallina S, Di Francesco A, Foti S. Proteins and bioactive peptides from donkey milk: the molecular basis for its reduced allergenic properties. Food Res Int. 2017;99:41–57.

[89] Gautam A, Chaudhary K, Kumar R, et al. In silico approaches for designing highly effective cell penetrating peptides. J Transl Med. 2013;11:1–12.

[90] Gupta S, Kapoor P, Chaudhary K, Gautam A, Kumar R, Raghava GPS. In silico approach for predicting toxicity of peptides and proteins. PLoS One. 2013;8(9): e73957.

[91] Gao X, Kim K-S, Liu D. Nonviral gene delivery: what we know and what is next. AAPS J. 2007;9:E92–E104.

[92] Hansen A, Schäfer I, Knappe D, Seibel P, Hoffmann R. Intracellular toxicity of proline-rich antimicrobial peptides shuttled into mammalian cells by the cell-penetrating peptide penetratin. Antimicrob Agents Chemother. 2012;56(10): 5194–5201.

[93] Chen J, Yu X, Chen Q, Wu Q, He Q. Screening and mechanisms of novel angiotensin-I-converting enzyme inhibitory peptides from rabbit meat proteins: a combined in silico and in vitro study. Food Chem. 2022;370:131070.

[94] Azman M, Sabri AH, Anjani QK, Mustaffa MF, Hamid KA. Intestinal absorption study: challenges and absorption enhancement strategies in improving oral drug delivery. Pharmaceuticals. 2022;15(8).

[95] Shen W, Matsui T. Current knowledge of intestinal absorption of bioactive peptides. Food Funct. 2017;8(12):4306–4314.

[96] Shen W, Matsui T. Intestinal absorption of small peptides: a review. Int J Food Sci \& Technol. 2019;54(6):1942–1948.

[97] Rivero-Pino F, Espejo-Carpio FJ, Guadix EM. Antidiabetic food-derived peptides for functional feeding: production, functionality and in vivo evidences. Foods (Basel, Switzerland). 2020;9(8).

[98] Ahmed T, Sun X, Udenigwe CC. Role of structural properties of bioactive peptides in their stability during simulated gastrointestinal digestion: a systematic review. Trends Food Sci Technol. 2022;120:265–273.

[99] Tu M, Cheng S, Lu W, Du M. Advancement and prospects of bioinformatics analysis for studying bioactive peptides from food-derived protein: sequence, structure, and functions. TrAC Trends Anal Chem. 2018;105:7–17.

[100] Udenigwe CC. Bioinformatics approaches, prospects and challenges of food bioactive peptide research. Trends Food Sci Technol. 2014;36(2):137–143.

[101] Silva do Nascimento E, Anaya K, de Oliveira JMC, et al. Identification of bioactive peptides released from in vitro gastrointestinal digestion of yam proteins (Dioscorea cayennensis). Food Res Int. 2021;143:110286.

[102] Zhou L, Budge SM, Ghaly AE, Brooks MS, Dave D. Extraction, purification and characterization of fish chymotrypsin: a review. Am J Biochem Biotechnol. 2011; 7(3):104–123.

[103] Ashaolu TJ, Lee CC, Ashaolu JO, Tarhan O, Pourjafar H, Jafari SM. Pepsin: an excellent proteolytic enzyme for the production of bioactive peptides. Food Rev Int. 2023:1–38.

[104] Malik D, Narayanasamy N, Pratyusha VA, Thakur J, Sinha N. Digestion and assimilation of nutrients. In: Textbook of Nutritional Biochemistry. Springer; 2023: 79–111.

[105] Dunaevsky YE, Tereshchenkova VF, Oppert B, Belozersky MA, Filippova IY, Elpidina EN. Human proline specific peptidases: a comprehensive analysis. Biochim Biophys Acta - Gen Subj. 2020;1864(9):129636.

[106] Amigo L, Hernández-Ledesma B. Current evidence on the bioavailability of food bioactive peptides. Molecules. 2020;25(19).

[107] Ahmed AS, El-Bassiony T, Elmalt LM, Ibrahim HR. Identification of potent antioxidant bioactive peptides from goat milk proteins. Food Res Int. 2015;74: 80–88.

[108] Šlechtová T, Gilar M, Kalíková K, Tesařová E. Insight into trypsin miscleavage: comparison of kinetic constants of problematic peptide sequences. Anal Chem. 2015;87(15):7636–7643.

[109] Whitcomb DC, Lowe ME. Human pancreatic digestive enzymes. Dig Dis Sci. 2007; 52(1):1–17.

[110] Shi Y, Wei G, Huang A. Simulated in vitro gastrointestinal digestion of traditional Chinese Rushan and Naizha cheese: peptidome profiles and bioactivity elucidation. Food Res Int. 2021;142:110201.

[111] Pak VV, Koo M, Kim MJ, Yang HJ, Yun L, Kwon DY. Modeling an active conformation for linear peptides and design of a competitive inhibitor for HMG-CoA reductase. J Mol Recognit. 2008;21(4):224–232.

[112] Istvan ES, Palnitkar M, Buchanan SK, Deisenhofer J. Crystal structure of the catalytic portion of human HMG-CoA reductase: insights into regulation of activity and catalysis. EMBO J. 2000;19(5):819–830.

[113] Pak VV, Koo M, Yun L, Kwon DY. Recognized sequence and conformation in design of linear peptides as a competitive inhibitor for HMG-CoA reductase. J Mol Recognit An Interdiscip J. 2007;20(3):197–203.

[114] Ruscica M, Macchi C, Morlotti B, Sirtori CR, Magni P. Statin therapy and related risk of new-onset type 2 diabetes mellitus. Eur J Intern Med. 2014;25(5):401–406.

[115] Kwon DY, Oh SW, Yang HJ, et al. Amino acid substitution of hypocholesterolemic peptide originated from glycinin hydrolyzate. Food Sci Biotechnol. 2002;11(1): 55–61.

[116] Pak VV, Koo M-S, Lee N-R, et al. Hypocholesterolemic soybean peptide (IAVP) inhibits HMG-CoA reductase in a competitive manner. Food Sci Biotechnol. 2005; 14(6):727–731.

[117] Fisayo Ajayi F, Mudgil P, Gan C-Y, Maqsood S. Identification and characterization of cholesterol esterase and lipase inhibitory peptides from amaranth protein hydrolysates. Food Chem X. 2021;12:100165.

[118] Heres A, Mora L, Toldrá F. Inhibition of 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase enzyme by dipeptides identified in dry-cured ham. Food Prod Process Nutr. 2021;3:1–14.

[119] Pak VV, Kim SH, Koo M, Lee N, Shakhidoyatov KM, Kwon DY. Peptide design of a competitive inhibitor for HMG-CoA reductase based on statin structure. Pept Sci Orig Res Biomol. 2006;84(6):586–594.

[120] Deslouches B, Di YP. Antimicrobial peptides with selective antitumor mechanisms: prospect for anticancer applications. Oncotarget. 2017;8(28):46635–46651.

[121] Winkler FK, D’Arcy A, Hunziker W. Structure of human pancreatic lipase. Nature. 1990;343(6260):771–774.

[122] Lunagariya NA, Patel NK, Jagtap SC, Bhutani KK. Inhibitors of pancreatic lipase: state of the art and clinical perspectives. EXCLI J. 2014;13:897–921.

[123] Urbizo-Reyes U, Liceaga AM, Reddivari L, Kim K-H, Anderson JM. Enzyme kinetics, molecular docking, and in silico characterization of canary seed (Phalaris canariensis L.) peptides with ACE and pancreatic lipase inhibitory activity. J Funct Foods. 2022;88:104892.

[124] Baba WN, Mudgil P, Baby B, Vijayan R, Gan C-Y, Maqsood S. New insights into the cholesterol esterase- and lipase-inhibiting potential of bioactive peptides from camel whey hydrolysates: identification, characterization, and molecular interaction. J Dairy Sci. 2021;104(7):7393–7405.

[125] Minkiewicz P, Iwaniak A, Darewicz M. BIOPEP-UWM database of bioactive peptides: current opportunities. Int J Mol Sci; 2021. https://biochemia.uwm.edu.pl/biopep-uwm/.Accessed April 22, 2022.

[126] Chakravarty B, Gu Z, Chirala SS, Wakil SJ, Quiocho FA. Human fatty acid synthase: structure and substrate selectivity of the thioesterase domain. Proc Natl Acad Sci. 2004;101(44):15567–15572.

[127] Chakravarthy MV, Zhu Y, López M, et al. Brain fatty acid synthase activates PPARα to maintain energy homeostasis. J Clin Invest. 2007;117(9):2539–2552.

[128] Sheng H, Niu B, Sun H. Metabolic targeting of cancers: from molecular mechanisms to therapeutic strategies. Curr Med Chem. 2009;16(13):1561–1587.

[129] Loftus TM, Jaworsky DE, Frehywot GL, et al. Reduced food intake and body weight in mice treated with fatty acid synthase inhibitors. Science (80). 2000;288(5475): 2379–2381.

[130] Martinez-Villaluenga C, Rupasinghe SG, Schuler MA, Gonzalez de Mejia E. Peptides from purified soybean β-conglycinin inhibit fatty acid synthase by interaction with the thioesterase catalytic domain. FEBS J. 2010;277(6):1481–1493.

[131] Tsou M-J, Kao F-J, Lu H-C, Kao H-C, Chiang W-D. Purification and identification of lipolysis-stimulating peptides derived from enzymatic hydrolysis of soy protein. Food Chem. 2013;138(2–3):1454–1460.

RIGHTS & PERMISSIONS

2024 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.